Metastatic Undifferentiated Pleomorphic Sarcoma
8 clinical trials · Condition
◉ Watch Metastatic Undifferentiated Pleomorphic Sarcoma
| Record | Firm | Date |
|---|---|---|
| Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study (NCT05017103) | M.D. Anderson Cancer Center | 2021-07-13 |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas (NCT03670069) | Fred Hutchinson Cancer Center | 2019-09-30 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma (NCT02601209) | National Cancer Institute (NCI) | 2015-11-30 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery (NCT02500797) | National Cancer Institute (NCI) | 2015-08-13 |
Track Metastatic Undifferentiated Pleomorphic Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.